Dicerna Pharmaceuticals Inc.

(NASDAQ: DRNA) Trade

By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

Dicerna Pharmaceuticals Inc is a biotechnology company involved in the discovery and development of innovative treatments for rare inherited diseases affecting the liver, along with cancers, and other therapeutic areas to address liver problems. The company is using ribonucleic acid interference (RNA) technology platform to develop its products. The product candidates are nedosiran (for primary hyperoxaluria), belcesiran (for genetic liver disease), DCR-PCSK9 (for cardiovascular disease), and RG6346 (for hepatitis B virus) among others.

Contact Information

Website: www.dicerna.com
Email: pschwartz@rxir.com
Main Phone: +1 617 621-8097
Address: 75 Hayden Avenue
State: MA
City / Town: Lexington
Country: US
Postal Code: 02421

Issuer Information

Exchange: NGS
CEO: Douglas M. Fambrough
Employees: 302
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)(541714)

Equities News

View More
(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A